Search for: "CELGENE" Results 161 - 180 of 183
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jul 2022, 1:36 am by Kurt R. Karst
  Indeed, it’s a bit late for the PTO to be trying to “understand” how FDA’s and the PTO’s authorities and responsibilities overlap; and references to “exploring the policies surrounding the use of ‘skinny labels,’” use codes, and REMS seem pretty dated more than four years after the first GSK decision brought skinny labeling front and center, almost 13 years since the Caraco decision ordering correction of a patent use code, and 15 years… [read post]
18 May 2011, 12:33 am by Marie Louise
COPEGUS (Class 46) Effexor (Venlafaxine) – US: Wyeth files patent infringement suit against Nostrum in response to Para IV challenge (Patent Docs) Escitalopram – Germany: Escitalopram revisited – Federal Patent Court rules in favor of validity of SPC for enantiomer over earlier marketing authorization for racemate (Kluwer Patent Blog) Fluticasone – US: Perrigo to settle all Hatch-Waxman litigation relating to Fluticasone lotion (GenericsWeb) Focalin (Dexmethylphenidate)… [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Doryx (Doxycycline) – US: Warner Chilcott files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Ebixa (Memantine) – Canada: Duty of good faith patent prosecution: Lundbeck v Ratiopharm (IP Osgoode) Focalin (Dexmethylphenidate) - US: Settlement announced in Focalin infringement dispute involving Celgene, Novartis Pharmaceuticals and Teva Pharmaceuticals (Patent Docs) Gemzar (Gemcitabine) – US: Patent infringement… [read post]
13 May 2010, 4:58 pm
(Patent Docs) Protonix (Pantoprazole) – US: Jury upholds validity of Pfizer's Protonix patent (Patent Docs) Ritalin (Methylphenidate) – US: Celgene and Novartis reach settlement with Barr Laboratories in Ritalin ANDA Suit (Patent Docs) Seasonale (Ethinyl estradiol, Levonorgestrel) – US: Watson reaches settlement with Teva over Seasonale (SmartBrief) Simcor(Simvastatin, Niacin) – US:Patent infringement complaint following a Paragraph IV certification: Abbott… [read post]
18 Mar 2010, 2:30 am
The case of generic Flomax – Hatch-Waxman backstory to approval of Impax first generic version of Boehringer Ingelheim’s Flomax (FDA Law Blog) Focalin (Dexmethylphenidate), Ritalin (Methylphenidate) - US: Settlement in ADHD patent infringement suits announced - Celgene Corp. and Novartis AG against defendants KV Pharmaceutical Co. and IntelliPharmaCeutics Corp (Patent Docs) (GenericsWeb) Neupogen (Filgrastim) – US: District Court N D Illinois: False marking complaint… [read post]
2 Nov 2007, 11:00 pm
: (PLI), (PatentDocs), (Patent Baristas), (Patently'O), Vonage settles patent dispure with Verizon: (IP Law360), Celgene and Novartis file extended release Ritalin suit: (IP Law360), T-Mobile USA is the latest to settle charges that it infringed technology for computerized sales methods held by patent-holding company Orion IP LLC: (IP Law360),Bayer beats Dr Reddy's on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals), Martek obtains permanent injunction agains… [read post]
27 Jan 2012, 5:00 am by Stephen Jenei
Thompson did not disclose that Agios was going to sell to Celgene Corporation an exclusive option to develop any drugs resulting from the cancer metabolism research platform. [read post]
6 Apr 2011, 12:18 am by Marie Louise
195/09 Synthon BV v Merz Pharma GmbH & Co KG (The SPC Blog) Amrix (Cyclobenzaprine) – US: Eurand files patent infringement complaint against Anchen in response to Para IV certification (Patent Docs) Asacol (Mesalamine) – US: NJ District Court punts in Asacol DJ action to trigger 180-day exclusivity forfeiture; Rules that subsequent ANDA applicant lacks standing: Medeva Pharma Suisse v Par Pharmaceuticals (FDA Law Blog) Cialis (Tadalafil) – Israel: Deja vu all over again –… [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
24 Jan 2012, 3:00 am by LindaMBeale
   Re those net short term capital gains:  Gingrich bought and sold shares in Campbell Soup in 2010 (losing 74), bought shares in Celgene Corp in 2009 and sold them in 2010 (making 2591), sold in 2010 shares in American Funds Capital bought at various times, for a 346 gain, and similarly sold shares in Nuveen High Yield fo a 1225 gain. [read post]
29 Jan 2019, 3:12 pm by Kevin LaCroix
Several large cases account for much of this effect, including the cases filed against Johnson & Johnson, Facebood, NVIDIA, Bristol-Myers Squibb and Celgene. [read post]
5 Jun 2016, 4:00 am by Administrator
Dans Celgene Corp. c. [read post]
15 Jul 2019, 8:09 am by Michael Geist
Technology transfer in the university context has emerged as significant policy issue with governments seeking to maximize the benefits of public investment in research at Canadian universities. [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Aug 2008, 12:54 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
25 Jul 2008, 7:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46)   Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]